Thromb Haemost 2004; 92(01): 223-224
DOI: 10.1055/s-0037-1613649
Letters to the Editor
Schattauer GmbH

Erythrocyte aggregation and −455G/A polymorphism of the β-fibrinogen gene in survivors of acute myocardial infarction

Amparo Vayá
,
Silvia Breña
,
Edelmiro Réganon
1   Thrombosis and Haemostasis Unit, Department of Clinical Pathology Research Center
,
Virtudes Vila
1   Thrombosis and Haemostasis Unit, Department of Clinical Pathology Research Center
,
Vicenta Martínez-Sales
1   Thrombosis and Haemostasis Unit, Department of Clinical Pathology Research Center
,
Maria Teresa Contreras
,
Esther Zorio
2   Cardiology Service, La Fe University Hospital
,
Dolores Corella
3   Department of Preventive Medicine School of Medicine, University of Valencia, Spain
,
Justo Aznar
› Author Affiliations
Further Information

Publication History

Received 20 February 2004

Accepted after revision 02 April 2004

Publication Date:
15 December 2017 (online)

 

 
  • References

  • 1 Demiroglu H. The importance of erythrocyte aggregation in blood rheology: Considerations on the pathophysiology of thrombotic disorders. Blood 1997; 89: 4236.
  • 2 Chien S, Jan KM. Red cell aggregation by macromolecules: roles of surface adsorption and electrostatic repulsion. J Sup Structure 1973; 01: 385-409.
  • 3 Nash GB, Wenby RB, Sowemimo-Coker SO. et al. Influence of cellular properties on red blood cell aggregation. Clin Hemorheol 1987; 07: 93-108.
  • 4 Weng X, Cloutier G, Genest Jr J. Contribution of the -455G/A polymorphism at the β-fibrinogen gene to erythrocyte aggregation in patients with coronary artery disease. Thromb Haemost 1999; 82: 1406-11.
  • 5 Vayá A, Falcó C, Réganon E. et al. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction. Thromb Haemost 2004; 91: 354-59.
  • 6 Thomas AE, Green FR, Kelleher CH. et al. Variation in the promoter region of b-fibrinogen levels in smokers and no-smokers. Thromb Haemost 1991; 65: 487-90.
  • 7 Heinrich J, Funke H, Rust S. et al. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1999; 77: 209-15.
  • 8 Scarabin PY, Bara L, Ricard S. et al. Genetic variation at the β-fibrinogen focus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb 1993; 03: 886-91.
  • 9 Behague I, Poirier O, Nicaud V. et al. β-fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Circulation 1996; 93: 440332-9.
  • 10 Leander K, Wiman B, Hallqvist J. et al. The G-455A polymorphism of the fibrinogen Bβ-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. J Int Med 2002; 252: 332-41.
  • 11 Green F, Hamsten A, Blomback M. et al. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-20.
  • 12 Carter AM, Stickland MH, Mansfield MW. et al. β-fibrinogen gene -455 G/A polymorphism and fibrinogen levels: Risk factors for coronary artery disease in subjects with NIDDM. Diabetes Care 1996; 19: 1265-8.
  • 13 Wang XL, Wang J, McCredie RM. et al. Polymorphisms of factor V, factor VII and fibrinogen genes: Relevance to severity of coronary artery disease. Arterioscl Thromb Vasc Biol 1997; 17: 246-51.
  • 14 Maghzal GJ, Brennan SO, George PM. Fibrinogen Bβ polymorphisms do not directly contribute to an altered in vitro clot structure in humans. Thromb Haemost 2003; 90: 1021-8.